Salud financiera de hoja de balance de Bliss GVS Pharma
Salud financiera controles de criterios 6/6
Bliss GVS Pharma tiene un patrimonio de accionistas total de ₹9.6B y una deuda total de ₹995.5M, lo que sitúa su ratio deuda-patrimonio en 10.3%. Sus activos y pasivos totales son ₹12.0B y ₹2.3B respectivamente. El BAIT de Bliss GVS Pharma es de ₹1.0B, por lo que su ratio de cobertura de intereses es de 48.7. Tiene efectivo e inversiones a corto plazo que ascienden a ₹1.6B.
Información clave
8.8%
Ratio deuda-patrimonio
₹878.07m
Deuda
| Ratio de cobertura de intereses | 18x |
| Efectivo | ₹2.16b |
| Patrimonio | ₹10.03b |
| Total pasivo | ₹2.11b |
| Activos totales | ₹12.14b |
Actualizaciones recientes sobre salud financiera
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25
Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly
Jul 21Recent updates
We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated
May 10Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Oct 07How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?
Sep 19What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?
Sep 04Have Insiders Been Buying Bliss GVS Pharma Limited (NSE:BLISSGVS) Shares?
Aug 17The Bliss GVS Pharma (NSE:BLISSGVS) Share Price Has Gained 43% And Shareholders Are Hoping For More
Aug 04Fewer Investors Than Expected Jumping On Bliss GVS Pharma Limited (NSE:BLISSGVS)
Aug 04Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly
Jul 21Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Jul 06Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹7.5B) de BLISSGVS superan a sus pasivos a corto plazo (₹1.7B).
Pasivo a largo plazo: Los activos a corto plazo de BLISSGVS (₹7.5B) superan a sus pasivos a largo plazo (₹620.5M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: BLISSGVS tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de BLISSGVS ha pasado de 12% a 10.3% en los últimos 5 años.
Cobertura de la deuda: La deuda de BLISSGVS está bien cubierta por el flujo de caja operativo (103%).
Cobertura de intereses: Los pagos de intereses de la deuda de BLISSGVS están bien cubiertos por el BAIT (48.7x cobertura).